{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1844121", "DateCompleted": {"Year": "1993", "Month": "04", "Day": "02"}, "DateRevised": {"Year": "2006", "Month": "11", "Day": "15"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0066-6769", "JournalIssue": {"Volume": "22", "Issue": "3-4", "PubDate": {"Year": "1991", "Season": "Jul-Dec"}}, "Title": "Archivos de investigacion medica", "ISOAbbreviation": "Arch Invest Med (Mex)"}, "ArticleTitle": "The effect of two sequential doses of Opuntia streptacantha upon glycemia.", "Pagination": {"StartPage": "333", "EndPage": "336", "MedlinePgn": "333-6"}, "Abstract": {"AbstractText": ["To find out if a second dose of O. streptacantha may enhance its hypoglycemic effect, three tests were performed in fasting condition to 8 type II diabetic subjects and 6 healthy individuals. The tests were as follows: A. 500 g of broiled stems of O. streptacantha were given orally initially and two hours later. B. Only the initial dose. C. Control test with water. Serum glucose and C peptide were measured every two hours from 0 to 6 hours. In diabetic patients a significant (P < 0.01 vs control) decrease of serum glucose reaching from 41 to 46% less than initial value, was noticed in tests A and B, without differences between them. C peptide did not change. In healthy subjects serum glucose and C peptide did not significantly differ between tests. A second dose of O. streptacantha, two hours after the first one, did not improve its hypoglycemic activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Internal Medicine, Hospital de Especialidades CMR, M\u00e9xico, D.F."}], "LastName": "Frati", "ForeName": "A C", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Xilotl D\u00edaz", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Altamirano", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ariza", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "L\u00f3pez-Ledesma", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Mexico", "MedlineTA": "Arch Invest Med (Mex)", "NlmUniqueID": "0262036", "ISSNLinking": "0066-6769"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["blood", "therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1991", "Month": "7", "Day": "1"}, {"Year": "1991", "Month": "7", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1991", "Month": "7", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1844121"]}}]}